The effect of sub-inhibitory concentrations of rifaximin on urease production and on other virulence factors expressed by Klebsiella pneumoniae, Proteus mirabilis, Pseudomonas aeruginosa and Staphylococcus aureus.
Rifaximin, a topical derivative of rifampin, inhibited urease production and other virulence factors at sub-MIC concentrations in strains involved in hepatic encephalopathy and the expression of methicillin resistance in Staphylococcus aureus. In particular, urease production was affected in all Proteus mirabilis and Klebsiella pneumoniae strains as well as in all tested Pseudomonas aeruginosa isolates. Other exotoxins, synthesized by P. aeruginosa, such as protease, gelatinase, lipase, lecithinase and DNAse were also not metabolized in the presence of rifaximin. This antibiotic inhibited pigment production in both P. aeruginosa and Chromobacterium violaceum, a biosensor control strain. Lastly, rifaximin affected haemolysin production in S. aureus and was able to restore cefoxitin susceptibility when the strain was cultured in the presence of sub-MICs of the drug. The present findings confirm and extend previous observations about the beneficial effects of rifaximin for the treatment of gastrointestinal diseases, since in this anatomic site, it reaches a large array of concentrations which prevents enterobacteria from thriving and/or producing their major virulence factors.
a Microbiology Section "C.A. Romanzi", DISC , University of Genoa , Genoa , Italy.
Annalisa
A
Ricci
a Microbiology Section "C.A. Romanzi", DISC , University of Genoa , Genoa , Italy.
Erika
E
Coppo
a Microbiology Section "C.A. Romanzi", DISC , University of Genoa , Genoa , Italy.
Ramona
R
Barbieri
a Microbiology Section "C.A. Romanzi", DISC , University of Genoa , Genoa , Italy.
Eugenio A
EA
Debbia
a Microbiology Section "C.A. Romanzi", DISC , University of Genoa , Genoa , Italy.
Anna
A
Marchese
D001424:Bacterial Infections / Q000188:drug therapy / Q000378:metabolism / Q000382:microbiology; D006801:Humans; D007711:Klebsiella pneumoniae / Q000187:drug effects / Q000378:metabolism*; D008826:Microbial Sensitivity Tests; D011513:Proteus mirabilis / Q000187:drug effects / Q000378:metabolism*; D011550:Pseudomonas aeruginosa / Q000187:drug effects / Q000378:metabolism*; D012294:Rifamycins / Q000494:pharmacology*; D000078262:Rifaximin; D013211:Staphylococcus aureus / Q000187:drug effects / Q000378:metabolism*; D014510:Urease / Q000378:metabolism*; D037521:Virulence Factors / Q000378:metabolism*
D012294:Rifamycins; D037521:Virulence Factors; D014510:Urease; D000078262:Rifaximin
Methicillin resistance; Quorum sensing; Rifaximin at sub-MIC concentrations; Urease production